Nirvana Life SciencesNIRV 
$0.0555.56%24h
55.56%24h
Global rank35839
Market cap$1.76M
Change 7d600.00%
YTD Performance250.00%
SP500 benchmarkOutperform
P/E-1.30
P/S0
Revenue$0
Earnings-$1.11M
Dividend yield-
Main Sector
Healthcare
Nirvana Life Sciences (NIRV) Stock Overview
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds. The company is headquartered in Vancouver, Canada.
NIRV Stock Information
Symbol
NIRVAddress
650 West Georgia StreetVancouver, BC V6B 4N8Canada
Founded
-Trading hours
-Website
https://nirvanalifescience.comCountry
🇨🇦 CanadaPhone Number
604-401-8100Nirvana Life Sciences (NIRV) Price Chart
-
Value:-
Nirvana Life Sciences Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $0.05187490736623685 | N/A |
| Market Cap | $1.76M | N/A |
| Shares Outstanding | 33.94M | -7.05% |
| Employees | 0 | N/A |
| Shareholder Equity | -939.79K | 481.58% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | -1.30 | N/A |
| P/B Ratio | -1.87 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 1.1761 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $0 | N/A |
| Earnings | -$1.11M | N/A |
| EPS | -0.04 | N/A |
| Earnings Yield | -0.7711 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $50.81K | N/A |
| Cash on Hand | $9.26K | N/A |
| Debt to Equity | -0.7951 | -73.25% |
| Current Ratio | 0.0680 | -69.38% |
